Oroville Hospital downgraded as cash availability slips

Oroville (Calif.) Hospital, which has faced questions over whether it can pay for a $178 million expansion project, has been downgraded to “B” amid operating challenges and violation of certain financial covenants, S&P Global said Sept. 29.

Advertisement

Describing the hospital system’s reserves as “vulnerable” with just 13 days’ cash on hand as of May 31, S&P said Oroville could improve its situation over the next few months but remains under pressure, including from the new project.

“We believe that the hospital is in a tighter position given the weak balance sheet and pressured operating environment, in conjunction with a new tower opening in early 2024 and higher debt service payments required over the next few years, which could limit reserve growth, particularly if cash flow remains lighter,” S&P said.

The outlook for the hospital system is negative given it has “very little financial cushion.”

Oroville Hospital has not responded to multiple attempts by Becker’s for further comment on its ability to pay for the expansion project now due to open next year.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.